Introduction. Experimental

Similar documents
International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010

Development and validation a RP-HPLC method: Application for the quantitative determination of quetiapine fumarate from marketed bulk tablets

Impact factor: 3.958/ICV: 4.10 ISSN:

Volume 6, Issue 2, January February 2011; Article-015

INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES

Rapid quantification of Chinese medicine Zuo Jin Pill using rapid resolution liquid chromatography

J Pharm Sci Bioscientific Res (4): ISSN NO

Department of Chemistry, JNTUACE, Kalikiri

Received: ; Accepted:

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

Simultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID

Method Development and Validation for the Estimation of Darunavir in Rat Plasma by RP-HPLC

Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form

RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation

SIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS.

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Simultaneous Determination of 11 Marker Compounds in Gumiganghwal-tang by HPLC-DAD and LC-MS

Extraction Process Validation of Isatis Radix

2.1 2,3 Dichloro Benzoyl Cyanide (2,3 DCBC) and survey of. manufactured commonly for the bulk drug industry, few references were

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

Application Note. Gas Chromatography/Mass Spectrometry/Food Safety. Abstract. Authors

Development of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation)

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Development And Validation Of Rp-Hplc Method For Determination Of Velpatasvir In Bulk

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

Trace analysis of mesityl oxide and diacetone alcohol in pharmaceuticals by capillary gas chromatography with flame ionization detection

Novus International Journal of Analytical Innovations 2012, Vol. 1, No. 3

Rapid Screening and Confirmation of Melamine Residues in Milk and Its Products by Liquid Chromatography Tandem Mass Spectrometry

Determination of underivatized aflatoxins B2, B1, G2, and G1 in ground hazelnuts by immunoaffinity solid-phase extraction with HPLC-FLD detection

RP-HPLC Method Development and Validation for Simultaneous Estimation of Nadifloxacin and Adapalene in Bulk and Dosage Form

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Development and validation of RP-HPLC method for determination of marker in polyherbal marketed Kankasava formulations

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

STABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG AND IT S PHARMACEUTICAL DOSAGE FORM

Appendix II- Bioanalytical Method Development and Validation

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Received: ; Accepted:

Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR THE ESTIMATION OF NICERGOLINE IN MARKETED FORMULATIONS

Rapid and simultaneous determination of paracetamol, ibuprofen and related impurity of ibuprofen by UPLC/DAD

Achieve confident synthesis control with the Thermo Scientific ISQ EC single quadrupole mass spectrometer

Determination of Gallic acid from their Methanolic Extract of Punica granatum By HPLC Method

RP-HPLC Estimation of Trospium Chloride in Tablet Dosage Forms

Low-level Determination of 4-Hydrazino Benzoic Acid in Drug Substance by High Performance Liquid Chromatography/Mass Spectrometry

Research Article Available online at

Research Article. Figure 1. Chemical structure of doxofylline. Indonesian J. Pharm. Vol. 24 No. 1 : ISSN-p :

Available online Research Article

Available online Journal of Chemical and Pharmaceutical Research, 2014, 6(8): Research Article

Available online Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article

Agilent 1200 Infinity Series HDR DAD Impurity Analyzer System for the Quantification of Trace Level of Genotoxic Impurity

Pharmacophore 2011, Vol. 2 (4), ISSN Pharmacophore. (An International Research Journal)

Department of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT

Fractionation of Acidic, Basic, and Neutral Drugs from Plasma with an SPE Mixed Mode Strong Cation Exchange Polymeric Resin (Agilent SampliQ SCX)

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method

A NEW HPLC METHOD FOR THE QUANTIFICATION OF PANTOPRAZOLE IN PHARMACEUTICALS

World Journal of Pharmaceutical and Life Sciences WJPLS

TLC Densitometric Quantification of Vasicine, Vasicinone and Embelin from Adhatoda zeylanica leaves and Embelia ribes fruits

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Validated First Order Derivative Spectroscopic Method for the determination of Stavudine in Bulk and Pharmaceutical Dosage Forms

SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC

Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS

Analysis of PEGylated Proteins with Agilent AdvanceBio SEC Columns

International Journal of Pharma and Bio Sciences A VALIDATED QUANTITATIVE DETERMINATION OF ALIZARIN IN RUBIA CORDIFOLIA LINN. BY ISOCRATIC RP-HPLC

DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN PLASMA AND FORMULATION

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

Pelagia Research Library

Development and Validation of GC-FID Method for the Quantification of N-Iodosuccinimide

DEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION

Research of Quality Standards for Stachydrine Hydrochloride in Chinese Medicine TJF Granule

HPLC Method Development and Validation for the estimation of Esomeprazole in Bulk and Pharmaceutical Dosage Form

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

A Reverse Phase Liquid Chromatography Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

Impact factor: 3.958/ICV: 4.10 ISSN:

Quantitative and Pattern Recognition Analyses for the Quality Evaluation of Herba Epimedii by HPLC

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Simultaneous estimation and validation of bromhexine and cephalexin in bulk and pharmaceutical dosage form by RP-HPLC method

Lonicera japonica Flower Dry Extract. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

A Simple, Novel Validated Stability Indicating RP-HPLC method for estimation of Duloxetine HCl in Capsule Pharmaceutical Formulation

Quantification of growth promoters olaquindox and carbadox in animal feedstuff with the Agilent 1260 Infinity Binary LC system with UV detection

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

Development and validation of stability indicating reverse phase high performance liquid chromatography method for Timolol Maleate

Sensitive HPLC Method for Triterpenoid Analysis Using Charged Aerosol Detection with Improved Resolution

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

Analysis of Stachydrine in Leonurus japonicus Using an Agilent ZORBAX RRHD HILIC Plus Column with LC/ELSD and LC/MS/MS

RP-HPLC Method for Simultaneous Estimation of Atenolol, Hydrochlorothiazide and Losarton in Tablet Dosage form

Available Online through

Pelagia Research Library

1Determination of optical purity of N-acetyl-1-naphthylethylamine by chiral chromatography and NMR spectroscopy

Development And Validation Of Stability Indicating RP-HPLC Method For Estimation Of Ledipasvir And Sofosbuvir

JMSCR Volume 03 Issue 03 Page March 2015

Analysis of Illegal Dyes in Food Matrices using Automated Online Sample Preparation with LC/MS

Journal of Advanced Scientific Research DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING RP-HPLC METHOD FOR ESTIMATION OF DABIGATRAN ETEXILATE

International Journal of Pharma and Bio Sciences V1(1)2010. HPLC method for analysis of Lercanidipine Hydrochloride in Tablets

International Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research

Transcription:

Natural Product Sciences 24(2) : 109-114 (2018) https://doi.org/10.20307/nps.2018.24.2.109 Simultaneous Determination of Four Compounds from Artemisia capillaris using High Performance Liquid Chromatography-Ultraviolet Detector (HPLC-UVD) and Their Quantitative Study in Artemisia Genus Kiwon Ko 1, In Kee Hong 2, Hyun-Jong Cho 1, Young Ho Kim 3, *, and Heejung Yang 1, * 1 College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea 2 R&D Center, Radiant Ltd., Chuncheon 24398, Republic of Korea 3 College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea Abstract Artemisia capillaris Thunb. (Compositae) is a native herb of East Asian countries and has used for the treatment of jaundice, high liver fever, and digestive diseases for a long time, as well as being developed as the source of herbal preparations until now. The major components from A. capillaris were chlorogenic acid (1) and its derivatives substituted with caffeoyl moieties, such as 3,5-dicaffeoylquinic acid (2) and 4,5-dicaffeoylquinic acid (3), and coumarins, such as scoparone. In the study, four compounds, chlorogenic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and scoparone (4) in the 70% ethanolic extract of A. capillaris were simultaneously determined by using HPLC-UVD system. This method was validated with the terms of linearity, precious and accuracy according to ICH guidelines. The developed method was successfully applied for the quantitative analysis of Artemisia genus, A. capillaris, A. iwayomogi, A. princeps, and A. argyi, distributed in Korea. Keywords Artemisia capillaris, Artemisia iwayomogi, Artemisia princeps, Artemisia argyi, Scoparone, HPLC-UV Introduction Artemisia capillaris Thunb. (Compositae) is an edible herbal medicine in Asian countries, Korea, China and Japan, for a long time. It has been traditionally used for the treatment of jaundice, high liver fever, and digestive diseases. 1,2 Extracts of A. capillaris and its components have the wide range of pharmacological activities, such as anti-inflammatory, hepatoprotective, and neuroprotective effects. 3-5 Also, it inhibited atopic dermatitis-like skin lesions, such as hyperkeratosis, hypertrophy and hemorrhage. 6 Major components of A. capillaris were simple phenolic compounds including of chlorogenic acid derivatives, coumarins and flavonoids. 7,8 Among them, scoparone, a coumarin derivative, is the marker compound of A. capillaris in a guideline for approval and declaration of herbal preparation (No. C0-2012-3-006) published by Ministry of Food and Drug Safety (MFDS), Korea. It can *Author for correspondence Young Ho Kim (Ph.D), College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea. Tel: +82-42-821-5933; E-mail: yhk@cnu.ac.kr Heejung Yang (Ph.D), College of Pharmacy, Kangwon National University,Chuncheon 24341, Republic of Korea. Tel: +82-33-250-6919; E-mail: heejyang@kangwon.ac.kr inhibit the release of inflammatory mediators in interferon-γ or LPS-stimulated RAW 264.7 and BV-2 cells. 9,10 Also it was reported that scoparone inhibited the NF-κB activity in phorbol 12-myristate 13-acetate-stimulated U937 cells. 11 In the present study, we developed the simultaneous determination of scoparone (SP), along with three phenolic compounds, chlorogenic acid (CA), 3,5-dicaffeoylquinic acid (3,5-DQA) and 4,5-dicaffeoylquinic acid (4,5-DQA), using HPLC-UV methods. Then, we applied the developed method for the quantification of four compounds in the dried herbs of Artemisia genus including of A. capillaris, A. iwayomogi, A. princeps, and A. argyi, which is being distributed in Korea. Experimental Chemicals and Reagents The 70% ethanolic extract of A. capillaris was gifted from Dr. In Kee Hong, R&D Center, Radiant Ltd. Briefly, it was prepared by Soxhlet extraction of dried A. capillaris (20 kg) with 70% ethanol (200 L) on 65 o C for 3 hr. Then the extract was powdered by freeze-drying and used for the HPLC analysis. CA, 3,5-DQA and 4,5-DQA were purchased from Chemfaces (Wuhan, Hubei, China). SP was provided by Dr. Hyun- Jong Cho, a professor of College of Pharmacy, Kangwon 109

110 Natural Product Sciences National University. Their purities were above 98%. HPLC-grade acetonitrile and water were purchased from TEDIA (Fairfield, OH, USA). Formic acid (FA) was purchased from Daejung Chemicals & Metals Co. Ltd. (Siheung, Korea). Plant Materials Thirty-one dried whole herbs of Artemisia samples, 5 of A. capillary, 16 of A. iwayomogi, 8 of A. princeps, and 2 of A. argyi, were provided from Prof. Young Ho Kim, a professor of College of Pharmacy, Chungnam National University, identified by Dr. Yong Soo Kwon, a professor of College of Pharmacy, Kangwon National University. The samples were deposited in the Herbarium of College of Pharmacy, Kangwon National University (KNUPH-AC-1~5 for A. capillaris, KNUPH- AI-1~16 for A. iwayomogi, KNUPH-AP-1~8 for A. princeps and KNUPH-AA-1~2 for A. argyi). HPLC Analytical Conditions The HPLC equipment used was consisted of a Agilent system (Agilent, Santa, CA, USA) connected with a pump (Agilent 1260 Quat Pump), an auto sampler (Agilent 1260 ALS), a column oven (Agilent 1260 TCC), UV detector (Agilent 1260 MWD). HPLC analysis was conducted on a HECTOR C18-M column (M51002546, 4.6 250 mm, i.d., 4.5-μm pore size). The mobile phase, 0.1% FA water (A) and acetonitrile (B) operating at a flow rate of 1.0 ml/min. The HPLC linear gradient profile was as follows: 10% B at 0 min, 10 12% B at 0 12 min, 12 16% B at 12 17 min, 16 25% B at 17 40 min, 25 38% B at 40 50 min, 38 10% B at 50 50.1 min, 10% B at 50.1 60 min. The injection volume was 10 μl. The column temperature was set at 35 o C and UV spectra was acquired at 330 nm. Preparation of Standard and Sample Solutions Standard stock solutions of CA, 3,5-DQA, 4,5-DQA and SP were prepared at the concentration of 1000 μg/ml in methanol. These standard stock solutions were diluted to 5 different concentrations, 10-500 μg/ml for each standard in methanol to establish the calibration curves. These standard stock solutions also mixed with samples and diluted to 3 different concentrations to validate method in precision and accuracy test, CA and 4,5-DQA added 100, 200 and 300 μg/ml, respectively, to the same amount of sample, and 3,5-DQA and SP added 20, 50 and 100 μg/ ml, respectively, to the same amount of sample. These sample stock solutions also mixed with samples and diluted to 3 different concentrations to validate method in precision test, 2, 5 and 10 mg/ml, respectively. Before HPLC analysis, all the sample solutions were filtered through a 0.45-μm membrane filter. Validation of the HPLC Method The established HPLC method was validated according to the ICH guidelines. The validation was performed in terms of linearity, precision, and accuracy. Calibration curves were established by plotting the peak area (y) versus concentration (x) of each standard. The correlation coefficient (R 2 ) values were used as a measure of linearity. Limit of detection (LOD) and quantification (LOQ) were determined using signal-to-noise ratios (S/N) of 3 and 10, respectively. For the precision results, intra- and inter-day test were performed to determine the precision of the developed HPLC analytical method. The relative standard deviation (RSD) was taken as a measure of repeatability. Then, recovery test was used to investigate the accuracy of this analysis method. The standard solutions with three different concentrations (100, 200 and 300 ppm) were added to the 70% ethanolic extract of A. capillaris (10 mg/ml) and then analyzed in triplicate. Quantification of Four Standards in the Dried Herbs of Artemisia genus The contents of four standards, CA, 3,5-DQA, 4,5-DQA and SP, were measured from thirtyone samples of Artemisia genus, A. capillaris (5 samples), A. iwayomogi (16 samples), A. princeps (8 samples) and A. argyi (2 samples) under the developed analytical condition. The box plot was visualized by the ggplot package in R software (ver. 3.4.1, R Core Team). Result and Discussion Optimization of Chromatographic Conditions Four compounds, CA, 3,5-DQA, 4,5-DQA and SP, were selected as the standards for the analysis of the 70% ethanolic extract of A. capillaris (Fig. 1). 7,9 The chromatographic conditions were developed to optimize chromatograms with good resolution between adjacent peaks. Three different columns, HECTOR C18-M column (4.6 250 mm, i.d., 4.5 μm), YMC-Triart C18 (4.6 250 mm, i.d., 5 μm) and Hypersil GOLD (4.6 250 mm, i.d., 5 μm), were applied to the HPLC-UV system, but a HECTOR C18-M column showed better performance for the separation of four standards than others and used to the further analyses. The solvent system buffered with 0.1% formic acid enhanced to resolution and lessening the peak tailing of the standards compared to 0.1% phosphoric acid. 12 In the optimized conditions, four standards, CA, 3,5-DQA, 4,5-DQA and SP, were eluted at 13.2, 36.9, 39.5 and 41.7 min, respectively (Fig. 2). All the UV spectra were measured at 330 nm, in which four standards were well absorbed (Fig. 3). Method Validation Calibration curves were plotted for each standard compound, and the relative regression

Vol. 24, No. 2, 2018 111 coefficients (R 2 ) were calculated to validate their linearities. All the calibration data of the four standard compounds showed good linearity (R 2 > 0.9997) in a relatively wide concentration range (Table 1). The LOD and LOQ values of all standard compounds were in the range 0.6 3.6 and 1.7 11.0 ng/ml, respectively, which showed a high sensitivity under the optimized conditions. The precision of the developed method was verified by intra- and interday variations, and it was expressed by the relative standard deviation (RSD). The RSD values of intra- and inter-day were less than 4.49% and 6.10%, respectively, which exhibited a good precision of the developed method (Table 2). To verify the accuracy, the standard solutions with three different concentrations were spiked to the 70% ethanolic extract of A. capillaris (10 mg/ml). Four standards were well recovered in the range of 92.52 104.64% (Table 2). Quantification of Four Standards in Artemisia genus Samples Thirty-one Artemisia samples distributed from Korea traditional herb markets were applied to quantify four standards, CA, 3,5-DQA, 4,5-DQA and SP under the analytical conditions developed in the method validation Fig. 1. Structures of four standards, chlorogenic acid (1), 3,5 dicaffeoylquinic acid (2), 4,5 dicaffeoylquinic acid (3) and scoparone (4), from A. capillaris. Fig. 2. HPLC chromatogram of four standards, chlorogenic acid (1), 3,5 dicaffeoylquinic acid (2), 4,5 dicaffeoylquinic acid (3), scoparone (4), and the 70% ethanolic extract of A. capillaris (5).

112 Natural Product Sciences Fig. 3. UV spectra of four standards, chlorogenic acid (1), 3,5 dicaffeoylquinic acid (2), 4,5 dicaffeoylquinic acid (3) and scoparone (4). Table 1. Calibration curves for LOD and LOQ of A. capillaris Compounds Retention time Linear regression equation R 2 LOD (µg) LOQ (µg) CA a 13.2 y = 25041x 92.957 0.9997 0.0021 0.0063 3,5-DQA 36.9 y = 36831x 162.99 0.9999 0.0029 0.0087 4,5-DQA 39.5 y = 29271x 139.2 0.9999 0.0036 0.0110 SP 41.7 y = 27270x 29.067 0.9999 0.0006 0.0017 a CA: chlorogenic acid, 3,5-DQA: 3,5 dicaffeoylquinic acid, 4,5-DQA: 4,5 dicaffeoylquinic acid, SP: scoparone Table 2. Precision and accuracy data of standard in A. capillaris Compounds Precision Intra day Inter day Spiked amount amount (µg/g) RSD (%) amount (µg/g) RSD (%) (µg/g) Accuracy Accuracy (%) CA a 3.072 1.409 1.489 1.420 3.000 102.41 1.41 3.365 4.499 0.659 3.218 3.508 95.92 4.50 2.488 0.090 2.922 2.762 2.500 99.54 0.09 3.347 1.796 0.600 0.675 3.523 95.02 1.80 3,5-DQA 2.988 1.839 1.422 5.617 3.023 98.87 1.84 2.455 1.501 3.002 2.573 2.523 97.33 1.50 0.746 0.966 0.143 1.276 0.806 92.52 0.97 4,5-DQA 0.525 0.691 0.304 5.096 0.556 94.38 0.69 0.389 1.208 0.618 5.480 0.406 95.75 1.21 0.806 1.487 0.132 0.934 0.788 102.27 1.49 SP 0.560 0.884 0.318 6.099 0.538 104.07 0.88 0.406 1.019 0.625 4.106 0.388 104.65 1.02 a CA: chlorogenic acid, 3,5-DQA: 3,5 dicaffeoylquinic acid, 4,5-DQA: 4,5 dicaffeoylquinic acid, SP: scoparone RSD (%)

Vol. 24, No. 2, 2018 113 Table 3. The amounts of four standards, CA, 3,5-DQA, 4,5-DQA and SP from Artemisia genus Mean ± SD (µg/g) CA a 3,5-DQA 4,5-DQA SP AC-1 b 2.83 ± 0.07 3.11 ± 0.05 0.64 ± 0.01 0.61 ± 0.05 AC-2 2.99 ± 0.06 3.25 ± 0.07 0.65 ± 0.01 0.63 ± 0.07 AC- 3 2.86 ± 0.07 3.01 ± 0.08 0.62 ± 0.01 0.63 ± 0.01 AC-4 1.49 ± 0.03 1.95 ± 0.03 0.89 ± 0.01 0.89 ± 0.01 AC-5 1.08 ± 0.06 1.64 ± 0.07 0.67 ± 0.02 0.74 ± 0.02 AI-1 2.18 ± 0.01 4.00 ± 0.01 2.06 ± 0.01 n.d. c AI-2 1.96 ± 0.06 6.03 ± 0.17 2.77 ± 0.05 n.d AI-3 1.67 ± 0.03 4.18 ± 0.13 1.42 ± 0.02 n.d AI-4 1.39 ± 0.03 2.05 ± 0.04 1.00 ± 0.01 n.d AI-5 1.06 ± 0.02 3.17 ± 0.06 2.01 ± 0.02 n.d AI-6 1.47 ± 0.02 3.47 ± 0.09 2.45 ± 0.04 n.d AI-7 1.10 ± 0.00 3.07 ± 0.00 1.08 ± 0.01 n.d AI-8 1.34 ± 0.04 3.73 ± 0.09 2.49 ± 0.04 n.d AI-9 1.17 ± 0.02 0.84 ± 0.02 1.75 ± 0.02 n.d AI-10 1.22 ± 0.05 3.81 ± 0.08 2.59 ± 0.03 n.d AI-11 2.36 ± 0.06 7.17 ± 0.01 1.93 ± 0.00 n.d AI-12 2.46 ± 0.02 7.35 ± 0.05 2.07 ± 0.01 n.d AI-13 2.40 ± 0.01 6.88 ± 0.03 1.97 ± 0.01 n.d AI-14 1.49 ± 0.04 3.89 ± 0.05 1.47 ± 0.01 n.d AI-15 1.62 ± 0.03 4.36 ± 0.07 1.66 ± 0.02 n.d AI-16 1.71 ± 0.08 4.15 ± 0.07 1.56 ± 0.02 n.d AP-1 1.08 ± 0.06 1.93 ± 0.01 1.84 ± 0.01 n.d AP-2 0.33 ± 0.01 1.00 ± 0.01 0.99 ± 0.00 n.d AP-3 1.25 ± 0.07 1.80 ± 0.01 1.74 ± 0.00 n.d AP-4 0.54 ± 0.03 0.92 ± 0.02 1.11 ± 0.02 n.d AP-5 1.02 ± 0.02 1.62 ± 0.04 1.45 ± 0.02 n.d AP-6 1.15 ± 0.09 2.28 ± 0.09 1.61 ± 0.05 n.d AP-7 0.49 ± 0.00 1.45 ± 0.03 0.98 ± 0.01 n.d AP-8 0.40 ± 0.01 1.25 ± 0.01 0.75 ± 0.01 n.d AA-1 0.32 ± 0.01 0.52 ± 0.01 0.58 ± 0.01 n.d AA-2 0.35 ± 0.01 1.03 ± 0.03 0.76 ± 0.01 n.d a CA: chlorogenic acid, 3,5-DQA: 3,5 dicaffeoylquinic acid, 4,5-DQA: 4,5 dicaffeoylquinic acid, SP: scoparone b AC: Artemisia capillaris, AI: Artemisia iwayomogi, AP: Artemisia princeps, AA: Artemisia argyi c n.d: not detected study. Interestingly, three standards except for SP were detected in all the samples, but their amounts were different according to the species (Table 3 and Fig. 4). Among four standards, SP, the standard for A. capillaris suggested in a guideline for approval and declaration of herbal preparation (No. C0-2012-3-006) published by Ministry of Food and Drug Safety (MFDS), was only measured in A. capillaris samples. Other phenolic compounds, CA, 3,5-DQA and 4,5-DQA, were present in all Artemisia samples, but their contents were different according to species. In particular, 3,5-DQA was the major compound in A. capillaris and A. iwaymogi, but even existed in different amounts in the same species. In this study, four compounds, CA, 3,5-DQA, 4,5-DQA and SP, in the 70% ethanolic extract of A. capillaris were simultaneously determined using HPLC-UV system and validated in terms of specificity, linearity, precision and accuracy. The validated method was successfully applied to quantify all four compounds in the Artemisia samples distributed in Korean traditional markets. Scoparone, which was only detected in A. capillaris samples, could be used as the chemical marker to distinguish A. capillaris

114 Natural Product Sciences Fig. 4. Boxplot of the content of four standards in thirty-one Artemisia genus samples, chlorogenic acid (1), 3,5 dicaffeoylquinic acid (2), 4,5 dicaffeoylquinic acid (3) and scoparone (4). from other Artemisia genus. Consequently, this method might be applied to analyze the extract of A. capillaris or the herbal preparations containing one or more of four compounds. Acknowledgements This research was supported by the Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region. References (1) Jang, E.; Kim, B. J.; Lee, K. T.; Inn, K. S.; Lee, J. H. Evid. Based Complement. Alternat. Med. 2015, 2015, 728137. (2) Islam, M. N.; Choi, R. J.; Jung, H. A.; Oh, S. H.; Choi, J. S. Arch. Pharm. Res. 2016, 39, 340-349. (3) Choi, M. K.; Han, J. M.; Kim, H. G.; Lee, J. S.; Lee, J. S.; Wang, J. H.; Son, S. W.; Park, H. J.; Son, C. G. J. Ethnopharmacol. 2013, 147, 662-670. (4) Chun, K. S.; Kang, J. Y.; Kim, O. H.; Kang, H.; Surh, Y. J. J. Environ. Pathol. Toxicol. Oncol. 2002, 21, 131-139. (5) Koo, B. S.; Lee, W. C.; Chang, Y. C.; Kim, C. H. Phytother. Res. 2004, 18, 142-148. (6) Ha, H.; Lee, H.; Seo, C. S.; Lim, H. S.; Lee, J. K.; Lee, M. Y.; Shin, H. BMC Complement. Altern. Med. 2014, 14, 100. (7) Park, K. M.; Li, Y.; Kim, B.; Zhang, H.; Hwangbo, K.; Piao, D. G.; Chi, M. J.; Woo, M. H.; Choi, J. S.; Lee, J. H.; Moon, D. C.; Chang, H. W.; Kim, J. R.; Son, J. K. Arch. Pharm. Res. 2012, 35, 2153-2162. (8) Okuno, I.; Uchida, K.; Nakamura, M.; Sakurawi, K. Chem. Pharm. Bull. 1988, 36, 769-775. (9) Jang, S. I.; Kim, Y. J.; Lee, W. Y.; Kwak, K. C.; Baek, S. H.; Kwak, G. B.; Yun, Y. G.; Kwon, T. O.; Chung, H. T.; Chai, K. Y. Arch. Pharm. Res. 2005, 28, 203-208. (10) Cho, D. Y.; Ko, H. M.; Kim, J.; Kim, B. W.; Yun, Y. S.; Park, J. I.; Ganesan, P.; Lee, J. T.; Choi, D. K. Molecules 2016, 21, E1718. (11) Jang, S. I.; Kim, Y. J.; Kim, H. J.; Lee, J. C.; Kim, H. Y.; Kim, Y. C.; Yun, Y. G.; Yu, H. H.; You, Y. O. Life Sci. 2006, 78, 2937-2943. (12) Tan, X. J.; Li, Q.; Chen, X. H.; Wang, Z. W.; Shi, Z. Y.; Bi, K. S.; Jia, Y. J. Pharm. Biom. Anal. 2008, 47, 847-853. Received January 23, 2018 Revised February 14, 2018 Accepted February 14, 2018